(-0.96%) 5 058.50 points
(-0.93%) 38 319 points
(-1.29%) 17 436 points
(0.47%) $83.20
(-0.67%) $1.642
(0.06%) $2 339.70
(0.23%) $27.41
(-0.24%) $913.60
(0.10%) $0.935
(0.08%) $10.99
(-0.07%) $0.802
(-0.34%) $92.01
Live Chart Being Loaded With Signals
StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy...
Stats | |
---|---|
Today's Volume | 89 100.00 |
Average Volume | 273 150 |
Market Cap | 26.75B |
EPS | ¥0 ( 2024-03-12 ) |
Next earnings date | ( ¥0 ) 2024-06-11 |
Last Dividend | ¥0 ( N/A ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 133.44 |
ATR14 | ¥0.232 (0.05%) |
Volume Correlation
StemRIM Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
StemRIM Correlation - Currency/Commodity
StemRIM Financials
Annual | 2023 |
Revenue: | ¥2.35B |
Gross Profit: | ¥2.30B (97.97 %) |
EPS: | ¥2.80 |
Q2 | 2024 |
Revenue: | ¥0 |
Gross Profit: | ¥-11.10M (0.00 %) |
EPS: | ¥-8.79 |
Q1 | 2024 |
Revenue: | ¥0 |
Gross Profit: | ¥-11.00M (0.00 %) |
EPS: | ¥-7.66 |
Q4 | 2023 |
Revenue: | ¥0 |
Gross Profit: | ¥-24.20M (0.00 %) |
EPS: | ¥-10.07 |
Financial Reports:
No articles found.
StemRIM
StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators